ClinVar Genomic variation as it relates to human health
NM_006205.3(PDE6H):c.35C>G (p.Ser12Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Pathogenic(2); Likely pathogenic(2); Uncertain significance(1)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_006205.3(PDE6H):c.35C>G (p.Ser12Ter)
Variation ID: 37245 Accession: VCV000037245.48
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 12p12.3 12: 14978047 (GRCh38) [ NCBI UCSC ] 12: 15130981 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Oct 20, 2024 Jan 12, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_006205.3:c.35C>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_006196.1:p.Ser12Ter nonsense NC_000012.12:g.14978047C>G NC_000012.11:g.15130981C>G NG_016859.1:g.10026C>G - Protein change
- S12*
- Other names
- -
- Canonical SPDI
- NC_000012.12:14978046:C:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00008
The Genome Aggregation Database (gnomAD) 0.00012
Trans-Omics for Precision Medicine (TOPMed) 0.00006
Exome Aggregation Consortium (ExAC) 0.00007
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
PDE6H | - | - |
GRCh38 GRCh37 |
65 | 104 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
no assertion criteria provided
|
Sep 7, 2012 | RCV000030807.5 | |
Conflicting interpretations of pathogenicity (4) |
criteria provided, conflicting classifications
|
May 23, 2022 | RCV000055928.14 | |
PDE6H-related disorder
|
Likely pathogenic (1) |
criteria provided, single submitter
|
Aug 23, 2018 | RCV000779093.5 |
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Jan 12, 2024 | RCV001092385.29 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(May 23, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Retinal cone dystrophy 3A
Affected status: yes
Allele origin:
germline
|
Institute of Human Genetics, Heidelberg University
Accession: SCV002556342.1
First in ClinVar: Aug 03, 2022 Last updated: Aug 03, 2022 |
Sex: male
|
|
Pathogenic
(Nov 01, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV001248872.26
First in ClinVar: May 12, 2020 Last updated: Oct 20, 2024 |
Number of individuals with the variant: 2
|
|
Likely pathogenic
(Aug 23, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
PDE6H-Related Disorders
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV000915582.1
First in ClinVar: May 27, 2019 Last updated: May 27, 2019 |
Comment:
The PDE6H c.35C>G (p.Ser12Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. The p.Ser12Ter variant has … (more)
The PDE6H c.35C>G (p.Ser12Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. The p.Ser12Ter variant has been reported in two studies and is found in a homozygous state in five probands from three families including two sibling pairs (Kohl et al. 2012; Pedurupillay et al. 2016). Three of the probands are diagnosed with incomplete achromatopsia and two with cone dystrophy. The unaffected parents of the siblings were confirmed heterozygotes for the p.Ser12Ter variant. The p.Ser12Ter variant was absent from 180 control subjects and is reported at a frequency of 0.000166 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the potential impact of stop-gained variants and evidence from the literature, the p.Ser12Ter variant is classified as likely pathogenic for PDE6H-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. (less)
|
|
Uncertain significance
(Dec 04, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Retinal cone dystrophy 3A
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001369732.2
First in ClinVar: Jul 04, 2020 Last updated: Dec 12, 2020 |
Comment:
This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to … (more)
This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to conclusively support its pathogenic nature. Thus this variant is classified as Uncertain significance - favor pathogenic. The following ACMG criteria were applied in classifying this variant: PP3,PP5. (less)
|
|
Pathogenic
(Jan 12, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002227721.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 14, 2024 |
Comment:
This sequence change creates a premature translational stop signal (p.Ser12*) in the PDE6H gene. It is expected to result in an absent or disrupted protein … (more)
This sequence change creates a premature translational stop signal (p.Ser12*) in the PDE6H gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PDE6H are known to be pathogenic (PMID: 22901948, 27472364). This variant is present in population databases (rs200311463, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with achromatopsia (PMID: 22901948, 27472364). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 37245). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Sep 07, 2012)
|
no assertion criteria provided
Method: literature only
|
ACHROMATOPSIA 6
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000053478.2
First in ClinVar: Apr 04, 2013 Last updated: Jan 01, 2021 |
Comment on evidence:
In a Dutch man and a Belgian brother and sister with incomplete achromatopsia (ACHM6; see 610024), Kohl et al. (2012) identified homozygosity for a 35C-G … (more)
In a Dutch man and a Belgian brother and sister with incomplete achromatopsia (ACHM6; see 610024), Kohl et al. (2012) identified homozygosity for a 35C-G transversion in exon 2 of the PDE6H gene, resulting in a ser12-to-ter (S12X) substitution predicted to result in a truncated protein of only 11 amino acids. The Belgian parents were heterozygous for the mutation, which was not found in any database query. Kohl et al. (2012) noted that the protein would likely represent a functional null allele, as it would lack all conserved domains relevant for transducin binding and inhibition of the catalytic activity of PDE; however, it was predicted to undergo nonsense-mediated decay. Haplotype analysis identified a common 301-kb haplotype flanked by rs111596034 (D12S2210) and rs2430621, suggesting that the S12X mutation resulted from a common ancestral mutational event in the 2 families. (less)
|
|
Pathogenic
(Oct 27, 2015)
|
no assertion criteria provided
Method: research
|
Retinal cone dystrophy 3A
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Department of Medical Genetics, Oslo University Hospital
Accession: SCV000256082.1
First in ClinVar: Oct 02, 2013 Last updated: Oct 02, 2013 |
Clinical Features:
Incomplete achromatopsia (present)
Family history: yes
Sex: male
Ethnicity/Population group: Pakistan
Tissue: leucocytes
Segregation observed: yes
Method: Whole exome sequencing was used to identify the variant and Sanger sequencing to verify segregation.
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001957650.1 First in ClinVar: Oct 02, 2021 Last updated: Oct 02, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001971195.1 First in ClinVar: Oct 07, 2021 Last updated: Oct 07, 2021 |
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Retinal cone dystrophy 3A
Affected status: unknown
Allele origin:
germline
|
GeneReviews
Accession: SCV000086940.3
First in ClinVar: Oct 02, 2013 Last updated: Apr 23, 2023 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Achromatopsia. | Adam MP | - | 2018 | PMID: 20301591 |
Segregation of Incomplete Achromatopsia and Alopecia Due to PDE6H and LPAR6 Variants in a Consanguineous Family from Pakistan. | Pedurupillay CR | Genes | 2016 | PMID: 27472364 |
A nonsense mutation in PDE6H causes autosomal-recessive incomplete achromatopsia. | Kohl S | American journal of human genetics | 2012 | PMID: 22901948 |
Text-mined citations for rs200311463 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.